Propolis supplementation AND Athletes

The effect of propolis supplementation on athletic performance and inflammatory markers and oxidative stress

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180824040857N2

Enrollment

Registered

2020-10-18

Start date

2020-09-05

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sports Nutrition. Biomechanical lesions, not elsewhere classified

Interventions

Intervention 1: Intervention group: Participants in the intervention group will receive an identical propolis tablet (450 mg, containing 300?mg Iranian green propolis extract and 150 mg microcrystalli

Eligibility

Sex/Gender

Male

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Male gender Exerciser Subjects with Body Mass Index

Exclusion criteria

Exclusion criteria: Female gender Cardiovascular diseases Metabolic diseases Diabetes Musculoskeletal Dysfunction Use of Propolis Supplement Use of Anti-inflammatory Drugs

Design outcomes

Primary

Measure	Time frame
Fatigue Index. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: RAST test.;Anaerobic Power. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: RAST test.;Aerobic Capacity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: Cooper test.;Interleukin-6. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: ELISA.;Interleukin-10. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: ELISA.;Catalase activity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.;Superoxide dismutase activity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.;Glutathione concentration. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.	—

Measure

Time frame

Fatigue Index. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: RAST test.;Anaerobic Power. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: RAST test.;Aerobic Capacity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: Cooper test.;Interleukin-6. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: ELISA.;Interleukin-10. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: ELISA.;Catalase activity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.;Superoxide dismutase activity. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.;Glutathione concentration. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: colorimetric method.

—

Secondary

Measure	Time frame
Alanine aminotransferase. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: Colorimetric method.;Aspartate aminotransferase. Timepoint: At the beginning of the study and fourth week of intervention. Method of measurement: Colorimetric method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaid Hadi

Artesh University of Medical Sciences

s.hadinu@yahoo.com+98 21 4382 2284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026